The landscape of dementia prognosis has evolved substantially with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology many years prior to symptoms arise. Even though these technological developments represent remarkable development in knowing neurodegenerative illnesses, they may have https://johnv454pvb1.win-blog.com/profile